Cyclins and cyclin-dependent kinases turn out to have diverse functions, not all directly concerned with the cell cycle; do they provide a link between cell-cycle control and other cellular processes?
Cyclin-Cdk complexes in transcriptional regulation
The transcription of a protein-coding gene requires assembly of a complex involving RNA polymerase II and various basal transcription factors (TFIIs) at the gene's promoter region. One of the basal transcription factors needed for initiation of transcription is TFIIH, which contains a protein kinase activity that phosphorylates the carboxy-terminal repeat domain (CTD) of the large subunit of RNA polymerase II [1] [2] [3] . The RNA polymerase II CTD is essential for transcription in vivo, and phosphorylation of the CTD is believed to be important for the release of the transcription complex from the promoter into an elongation mode [4] .
TFIIH of the budding yeast, Saccharomyces cerevisiae, is itself a multi-subunit protein, composed of SSL2, a five subunit core and a three subunit complex (separately designated TFIIK) which is the site of TFIIH's CTD-kinase activity. Several subunits of mammalian TFIIH are known nucleotide-excision repair proteins, and there is good evidence that TFIIH is involved in nucleotide-excision repair. Cell-cycle control has recently been linked to transcription and DNA repair by the identification of cycin H and Cdk7 as two of the three subunits of TFIIK [5] [6] [7] [8] . Indeed, microinjection of anti-Cdk7 antibodies into fibroblasts inhibits both transcription and nucleotideexcision repair, suggesting that Cdk7 activity may have a direct role in the nucleotide-excision repair activity associated with TFIIH [6] , although this result could also be explained by the known coupling between transcription and repair.
The finding that cyclin H and Cdk7 are components of TFIIH is somewhat unexpected, as they were previously identified as the components of Cdk-activating kinase (CAK), which phosphorylates the threonine in the activation loop of other Cdks. Phosphorylation of this threonine -Thrl61 in Cdc2 -is a prerequisite for the maximal activation of Cdks [9] . Cdk7 is a nuclear protein and, unlike many regulators of Cdk, the protein level and activity of Cdk7 does not vary in the cell cycle, apart from a reduction in GO. Immunoprecipitation studies of Cdk7 show that CAK contains a third subunit in addition to cyclin H and Cdk7 [10] , which in retrospect is likely to be the same as the third subunit in TFIIK. Three groups have recently cloned this third subunitcalled MAT1, for 'M6nage a Trois' -and found it to be a novel, 36 kDa protein with an amino-terminal zinc finger of the C 3 HC 4 , or 'RING', variety [11] [12] [13] .
Although cyclin H and Cdk7 can form a complex in vitro, the affinity of this interaction is low. Binding of MAT1 to cyclin H-Cdk7 stabilizes the complex and produces higher CAK activity. The RING finger motif of MAT1 is dispensable for its association with cyclin H-Cdk7 [11, 13] . The equivalent residue in mouse Cdk7 to Thrl61 in Cdc2 is Thrl70, and it appears that phosphorylation of this threonine is also required for activation of CAK. There is, however, no evidence that CAK autophosphorylates, so CAK must in turn be activated by another Cdk-like, CAK-activating kinase (CAKAK). There is evidence that cyclin A-Cdk2 and cyclin B-Cdc2 can serve as CAKAKs in vitro. Phosphorylation of Cdk7 residue Thr170 facilitates cyclin H-Cdk7 complex formation, and produces active CAK without a requirement for MAT1 [12] . Intriguingly, in the presence of MAT1, phosphorylation of Thrl70 appears to be dispensable for CAK activity [11, 12] . MAT1 thus serves as both an assembly factor for cyclin H-Cdk7 and a substitute for phosphorylation by CAKAK.
Unlike cyclin H-Cdk7, the budding yeast homologue CCL1-KIN28 has CTD kinase activity but does not have CAK activity when tested in vitro [5, 14] . At present, the identity of yeast CAK is unknown, but assuming that CCL1-KIN28 is not CAK, one is apparently forced to the surprising conclusion that CAK and the TFIIH CTD kinase are distinct enzymes in yeast, whereas in higher eukaryotes cycin H-Cdk7 performs both functions. If true, this would be in stark contrast to what has been found for most other cell-cycle regulators, where the number of genes involved at each step has multiplied, rather than decreased, in progressing from yeast to higher eukaryotes. In fact, based on this logic one might predict that other CAKs exist in vertebrates; identification of the yeast CAK would go a long way to resolving this issue.
One key question is whether the cyclin H-Cdk7-MAT1 complex is the bona fide CAK in vivo. Most evidence suggests that cyclin H-Cdk7-MAT1 accounts for the majority of the CAK activity in a cell. Thus, cyclin H-Cdk7 is the only CAK activity detected during purification [15, 16] , and immunodepletion of each of the three subunits of CAK depletes all the CAK activity in cell extracts (M. Dore, personal communication). About half of the cycin H-Cdk7-MAT1 complex is not associated with transcription factors [12] , suggesting that this kinase exists in two populations, one functioning as CAK. and the other in TFIIH (Fig. 1) . It is, of course, conceivable that there is a much weaker, or more labile, activity in the cell that can also serve as CAK. One reason for believing this is that such an activity could explain how the Cdc2 in cyclin B-Cdc2, which is in the cytoplasm, can be phosphorylated on Thrl61, when CAK is in the nucleus. One possibility is that there is a cytoplasmic CAK that is associated with membranes and so was missed during purification.
Cyclin H-Cdk7 also has an atypical substrate specificity for a cycin-Cdk pair. Cdks generally phosphorylate substrates that have a proline after the target hydroxyamino acid (Ser/Thr-Pro), but purified CAK can phosphorylate both Ser/Thr-Pro sites (as in Cdk4 and CTD) and nonSer/Thr-Pro sites (such as Thr-His in Cdc2 and Cdk2), yet cannot phosphorylate conventional Cdk substrates like histone H1. In the case of cAMP-dependent protein kinase, selection of the residue following the target hydroxyamino acid is dictated by a pocket that binds the P+1 residue. A P+1 pocket is present in all known protein kinase structures, and in Cdk2 this pocket is designed to accommodate a proline [17] . The ability of CAK to phosphorylate Thr161, where the P+1 residue is a histidine, is therefore surprising. If the P+1 pocket in Cdk7 is like that in Cdk2, this would mean that other interactions between CAK and the cycin-Cdk complex would have to override the normally strict requirement for a proline at P+1. The alternative is that the true cyclin H-Cdk7 substrates are those that contain Ser/Thr-Pro sites, and that there is another kinase that phosphorylates the threonine in the activation loops of the Cdks in vivo.
Another possible explanation for this conundrum is that the CAK in TFIIH is required to activate another cycin-Cdk pair in the transcription complex, which in turn is the true CTD kinase. Just such a cyclin-Cdk complex, which can phosphorylate the CTD, has recently been identified in the yeast RNA polymerase II holoenzyme. Partial truncation of the CTD gives rise to a cold-sensitive phenotype in yeast; mutations in genes SRB10 and SRB11 suppress this cold-sensitive phenotype [18] . SRBIO encodes a Cdk-related protein kinase, and SRB11 encodes a cyclin-like protein that is most closely related to cyclin C. SRB10 and SRB11 proteins form a complex and are associated with the RNA polymerase II holoenzyme.
Cells containing mutations in either SRB10 or SRB11 respond poorly to transcriptional induction in vivo. Moreover, CTD phosphorylation in vitro is reduced -10-fold when the RNA polymerase II holoenzyme is derived from cells containing a kinase-inactive mutant SRB10, suggesting that SRB10-SRBll may be able to phosphorylate CTD and regulate transcription. When assayed in vitro, however, no difference in basal and activated transcriptional activities was observed between RNA polymerase II containing wild-type or mutant SRB10, suggesting that the regulatory function of SRB10-SRB11 may involve more than the phosphorylation of the CTD, or else that some other factors are absent from the in vitro purified system. Similarly, TFIIH containing a kinase-inactive mutant of Cdk7 lacks CTD kinase activity, yet both basal and activated transcription in vitro are normal [19] . It will be important to learn whether cyclin H-Cdk7 and SRB10-SRBll affect each other's activity in the transcription initiation complex. Possible homologues of SRB311 and SRB10 are known in mammalian cells, namely cyclin C (originally cloned as a G1 cyclin) and its partner Cdk8, respectively [20] . Like cyclin H-Cdk7, cyclin C-Cdk8 may also prove to have a dual role in cell-cycle and transcriptional control. Another potential twist of the story is provided by the recent identification of yet another cyclin-Cdk complex in yeast, CTK2-CTK1, which can also phosphorylate CTD [21] . CTK1 is a Cdk-related protein kinase, CTK2 is related to cyclin C, and the CTK2-CTK1 complex is associated with a novel 32kDa protein, CTK3.
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Cyclin-Cdk complexes in phosphate metabolism
The budding yeast gene PH05 encodes a secreted acid phosphatase, and its transcription is induced by starvation for inorganic phosphate. The PHO5 enzyme is positively regulated by PHO2, PHO4 and PHO81, and negatively regulated by PHO80 and PHO85. PHO80 is a cyclin with homology to two yeast cyclins, PCL1 (HSC26) and PCL2 (ORFD) [22] [23] [24] , and PHO85 is a Cdk [25] . The PHO80-PHO85 complex can interact with and phosphorylate PHO4, a basic-helix-loop-helix transcription factor that binds to the PH05 promoter [23] . Phosphorylation of PHO4 by PHO80-PHO85 correlates well with the repression of PH05 expression. Phosphorylation of PHO4 decreases its binding to the PHOS upstream activating sequence (UAS), apparently by preventing interaction with the homeodomain protein PHO2, which is required for PHO4 to bind to the low affinity PH05 UAS [26] .
Like many cyclin-Cdk complexes involved in cell-cycle control, PHO80-PHO85 can also be inhibited by a Cdk-inhibitor, PHO81 [27] . Like the p6NK4 family of Cdk-inhibitors, PHO81 contains ankyrin repeats, and this region alone is able to inhibit PHO80-PHO85 in vitro [27] . The region containing the last two ankyrin repeats has been identified as the minimum region required for PHO81 function [28] . PHO81 binds to PHO80, but does not displace PHO85 from PHO80 [26, 27] , thus differing from the action of pl6INK 4 family
Cdk-inhibitors, which bind to Cdk4/6 and preclude binding of the D-type cyclin.
The reduction of PHO80-PHO85's activity upon phosphate starvation could in principle be explained by the fact that PH081 transcription is induced in response to phosphate starvation [29] . Intriguingly, however, the amount of PHO81 associated with PHO80-PHO85 is the same irrespective of whether the cells are grown in the presence of high or low phosphate [27] , suggesting that the inhibitory activity of PHO81 towards PHO80-PHO85 may be regulated post-translationally.
In support of this, PHO81-PHO80 was found to associate with PHO4 in high phosphate, but the complex dissociates from PHO4 in low phosphate, thus exposing the PHO4 activation domain [26] . It is therefore possible that it is only when cells are starved for phosphate that PHO81 can inhibit the kinase activity of PHO80-PHO85, leading to decreased phosphorylation of PHO4 and activation of PH05 transcription (Fig. 2) .
Interestingly, the same Cdk subunit, PHO85, can also interact with two other cyclin subunits, PCL1 and PCL2 [22, 24] . PCL1-PHO85 and PCL2-PHO85 complexes appear to be involved in the regulation of G1 phase of the cell cycle. The expression of PCL1 and PCL2 is controlled by the transcription factor SWI4 and peaks in G1 [30, 31] . The exact roles of PCL1-PHO85 and PLC2-PHO85 in cell-cycle control are, however, unclear. PHO85 is non-essential and is required for G1 progression only when the G1 cyclins CLN1 and CLN2 are absent [22] . Similarly, deletion of PCL1 or PCL2 has no effect on the cell cycle, but they are required for G1 progression when CLN1 and CLN2 are absent [22, 24] . It is possible that PCL1-PHO85 and PCL2-PHO85 perform some G1 function that is only manifested when the other G1 cyclins are absent. The PCL1/PCL2-PHO85 complexes are likely to have different substrate targets to CLN-CDC28, as suggested by their different substrate specificities in vitro (PCL1/PCL2-PHO85 complexes phosphorylate PHO4 and not conventional CLN-CDC28 substrates [22,24J) ; this may explain why overexpression of PH085 cannot complement a CDC28 deletion [25] .
Why use one protein kinase for multiple biological functions?
By existing in different contexts -Cdk7 in CAK or TFIIH -or in different disguises -PHO85 binding to PHO80 or PCL1/PCL2 -a single Cdk can thus take part in cell-cycle control as well as in other, very different processes, like transcription and phosphate metabolism. Why would a cell employ one protein kinase to regulate two unrelated processes? One possibility is that this is simply an example of efficient protein kinases doing double duty. For instance, cyclin H-Cdk7 could be used in different processes because it just happens to be a constitutively active kinase that is able to phosphorylate different substrates depending on associations mediated by the cyclin H-Cdk7-containing holoenzyme. Thus, cyclin H-Cdk7-MAT1 can phosphorylate Thrl6 or equivalent residues through a specific association with cyclin-Cdk complexes, or it can phosphorylate the RNA polymerase CTD when it is part of TFIIH. However, as evolution has placed little restriction on genome size, 'good ideas' have generally been reused by gene duplication, rather than by literally using the same protein for two purposes.
A far more attractive explanation, therefore, is that these multifunctional cyclin-Cdks represent a means of coordinating cell-cycle progression with other processes, such as transcription and DNA repair. For example, the availability of CAK for Cdk activation or transcription may decrease when DNA repair is required. Although the total level of CAK is constant, the pool of cyclin H-Cdk7 available for Cdk activation or transcription/ repair may vary under different circumstances. It is possible that more CAK is recruited into TFIIH complexes after DNA damage, slowing the cell-cycle progression to allow time for DNA repair. Another possible substrate for CAK that would provide a link between DNA repair and cell-cycle arrest is the tumor suppressor p 5 3 , which interacts with TFIIH [32] via XPB and XPD. It is possible that when RNA polymerase is stalled at DNA damage sites, Cdk7 in TFIIH phosphorylates p53 and enhances some p53-mediated function, such as induction of the Cdk inhibitor p21.
By its ability to bind to different subunits, PH085 shows how a single Cdk subunit can act in two distinct biological processes. It would be of great interest to learn whether PH085 provides a link between environmental signals and cell-cycle control. Phosphate starvation may inhibit the activity of PHO80-PH085 as well as the activity of PCL1/PCL2-PH085 complexes, perhaps through the activation of PHO81. Although inhibition of PH085 alone would not arrest the cell cycle, it may provide subtle tuning of the cell cycle.
Like PH085, mammalian Cdk5 may also be able to perform different functions by associating with different subunits. Cdk5 is found complexed with D-type cyclins in fibroblasts or with a distinct activating subunit, p35, in postmitotic neuronal cells [33] . The function of the p35-Cdk5 complex is not yet known, but it is highly active when isolated from neurons, suggesting that it plays a role in these postmitotic cells. Unlike other cyclin-Cdk complexes, which are nuclear, p35-Cdk5 is localized in the axonal cytoplasm and may phosphorylate the microtubule-associated protein tau. The role, if any, of Cdk5 in the mitotic cell cycle is unclear, as a dominant-negative mutant of Cdk5 does not arrest fibroblasts, unlike the equivalent Cdk2 and Cdc2 mutants. Interestingly, activation of p35-Cdk5 does not require phosphorylation of the equivalent residue to Thr161 in Cdc2, which is reminiscent of the activation of cyclin H-Cdk7 by MAT1. p 3 5 has essentially no sequence homology with the cyclins, raising the issue of whether there are other examples of non-cyclin activating subunits of Cdks. The fact that the crystal structure of cyclin A contains two domains of similar structure but very different sequence [34] opens up the possibility that proteins like p35 may also have a cyclin-like structure, even though they have little homology to cyclins.
In this connection, it is worth noting that cyclins are not only activating subunits for Cdks but are also targeting subunits that provide information for proper subcellular localization, as well as promoting direct interaction of cyclin-Cdk complexes with individual proteins, thus dictating substrate specificity. This two-subunit system provides great flexibility and allows a single protein kinase to function in different ways, while still potentially being subject to common controls.
Recent years have seen the minimalist idea that the cell cycle is driven by a single cycin-Cdk complex become very elaborate. Many cychin-Cdk complexes are now known to control different points of the cell cycle, each being regulated by a complex network of protein kinases and phosphatases and protein kinase inhibitors. We are also beginning to realize that some cyclin-Cdks have functions other than in direct cell-cycle control. It is likely that more non-cell-cycle functions of cyclins and Cdks will be discovered, as to date most of the focus has been on identifying their predicted cell-cycle roles. These delinquent cycin-Cdk complexes may well provide a link between cell-cycle progression and other processes in the cell.
